Hogan Lovells logo
  • Our people
  • What we do
    Sectors Practices Legal Tech
    • Aerospace and Defense
    • Automotive and Mobility
    • Consumer
    • Education
    • Energy
    • Financial Institutions
    • Insurance
    • Life Sciences and Health Care
    • Manufacturing and Industrials
    • Private Capital
    • Real Estate
    • Sports, Media and Entertainment
    • Technology
    • Transportation and Logistics
    • Corporate & Finance
    • Disputes
    • Intellectual Property
    • Regulatory
  • Case studies
  • Our thinking
    • All Our thinking
    • Comparative guides
    • Digital Client Solutions
    • Events and webinars
    • Podcasts
    News image_2

    Reflecting on President Trump’s first 100 days in office

  • ESG
  • Careers
Search Search
close
Search Search Search
lang-sel-icon English
  • Deutsch
  • English
  • Español
  • Français
  • 日本語
  • 中文
False
people-new
Mobile area
  • About us
    • Our difference
    • Global management team
  • Where we are
    • Our locations
    • Law Firm Network
  • Media center
    • Media contacts
    • Press releases
    • Awards & rankings
  • Responsible Business
  • HL Inclusion
  • Alumni
LinkedIn
Youtube
twitter
Wechat
Hogan Lovells Our thinking banner ""

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.
Back to Our thinking
Topics
Countries
Language
Date
Clear
"{0}"

    Insights and Analysis

    MDCG published new guidance on the interplay between the MDR & IVDR and the AI Act
    20 June 2025

    Insights and Analysis

    A prescription for corruption risks in the Asian healthcare sector
    19 June 2025

    News

    New MDCG guidance clarifies rules for medical device software available on online platforms
    18 June 2025

    News

    New Oregon CPOM law takes aim at “Friendly PC” arrangements
    18 June 2025

    Insights and Analysis

    Be vigilant: new post-market surveillance requirements for medical devices in Great Britain take effect
    16 June 2025

    News

    FDA finalizes 2025 Q-Submission Guidance, streamlining interactions for device sponsors and proposes electronic submission mandate for Q-Submissions using eStar
    16 June 2025

    News

    Robbinhood ransomware hacker pleads guilty to charges stemming from 2019 attack on Baltimore
    13 June 2025

    News

    EU Pharma Law Package: Council Position on Reduction of Regulatory Exclusivity Rights
    10 June 2025

    News

    OFAC lifts certain sanctions on Syria, broad export controls remain in place
    09 June 2025

    News

    FDA clarifies 510(k) clearance transfer rules in new Q&A guidance
    06 June 2025

    News

    Take It Down Act: U.S. enacts law targeting sexually explicit deepfakes and “revenge porn”
    02 June 2025

    News

    PRODUCT | Spring round-up: Navigating developments across products law
    31 May 2025

    No results found

    Load more

    "" ""
    Digital Client Solutions
    Empowering you to lead change through our digital solutions.
    Learn more
    Hogan Lovells logo
    Contact us
    Quick Links
    • About us
    • Careers
    • Case studies
    • Contact us
    • HL Inclusion
    • Our people
    • Our thinking
    • Responsible Business
    • Cookies
    • Disclaimer
    • Fraudulent and Scam Emails
    • Legal notices
    • Modern Slavery Statement
    • Our thinking terms of use
    • Privacy
    • RSS
    Connect with us
    LinkedIn
    Youtube
    Twitter
    Wechat
    Stay in the know

    © 2025 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.

    Subscribe to Our thinking
    Connect with us
    LinkedIn
    Youtube
    Twitter
    Wechat